[ALA] QoQ Quarter Result on 30-Sep-2021 [#Q1]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Sep-2021
Financial Year
2022
Quarter
30-Sep-2021 [#Q1]
Profit Trend
QoQ- 40.15%
YoY- -125.97%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 273 137 23 11 15 319 243 8.09%
PBT -4,671 -2,335 -3,950 -1,975 -3,923 -1,650 -1,756 92.32%
Tax -0 0 -0 0 -623 0 -9 -
NP -4,671 -2,335 -3,950 -1,975 -3,300 -1,650 -1,747 92.98%
Tax Rate - - - - - - - -
Total Cost 4,944 2,472 3,973 1,986 3,315 1,969 1,990 83.74%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -1,709.47 -1,709.48 -17,484.78 -17,484.01 -22,288.88 -517.19 -720.44 78.18%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 0.00%
EPS Diluted -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.